|
Dual Eligibles With Mental Disorders And Medicare Part D: How Are They Faring?
Julie M. Donohue,
Haiden A. Huskamp and
Samuel H. Zuvekas
In 2006, six million beneficiaries who were eligible for both Medicare and Medicaid switched from Medicaid to Medicare Part D for coverage of their prescription drugs. This change led to an expanded role for Medicare in financing psychotropic medications for dual eligibles. A reduction in the number of plans serving these beneficiaries and an increase in utilization restrictions for some psychotropics since 2006 raise concerns about access to medications for dual eligibles with mental disorders and point to potential problems with adverse selection. To improve access for this population, Medicare might consider changes to its enrollment and risk-sharing systems.
       What's this?
Related Articles
Pharmaceuticals & Psychotropic Drugs
Health Affairs,
May/June
2009; 28(3):
723
[Extract]
[Full Text]
[PDF]
- Susan H. Busch and Colleen L. Barry
Pediatric Antidepressant Use After The Black-Box Warning
Health Affairs,
May/June
2009; 28(3):
724-733.
[Abstract]
[Full Text]
[PDF]
- Haiden A. Huskamp, Alisa B. Busch, Marisa E. Domino, and Sharon-Lise T. Normand
Antidepressant Reformulations: Who Uses Them, And What Are The Benefits?
Health Affairs,
May/June
2009; 28(3):
734-745.
[Abstract]
[Full Text]
[PDF]
[Appendix]
This article has been cited by other articles:
|
|
|
|
 
M. Horvitz-Lennon, J. M. Donohue, M. E. Domino, and S.-L. T. Normand
Improving Quality And Diffusing Best Practices: The Case Of Schizophrenia
Health Aff.,
May 1, 2009;
28(3):
701 - 712.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
